Onyx Healthcare Inc. (TPEX:6569)
Taiwan · Delayed Price · Currency is TWD 97.70
+0.40 (0.41%)
Jul 30, 2026, 9:49 AM CST
Onyx Healthcare Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,802 | 4,278 | 5,908 | 5,763 | 3,253 | 3,162 | |
Market Cap Growth | -12.22% | -27.59% | 2.52% | 77.16% | 2.87% | -11.58% |
Enterprise Value | 3,869 | 4,226 | 5,899 | 5,629 | 3,085 | 3,323 |
Last Close Price | 97.30 | 105.11 | 141.96 | 136.21 | 74.71 | 75.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.26 | 38.15 | 32.66 | 22.58 | 16.03 | 24.79 |
Forward PE | - | 26.48 | 26.48 | 26.48 | 26.48 | 26.48 |
PS Ratio | 2.75 | 3.26 | 4.76 | 3.86 | 2.03 | 2.63 |
PB Ratio | 2.37 | 2.73 | 3.81 | 3.79 | 2.32 | 3.06 |
P/TBV Ratio | 2.37 | 2.73 | 3.83 | 3.82 | 2.35 | 3.10 |
P/FCF Ratio | 158.11 | 29.01 | 50.27 | 20.37 | 21.71 | - |
P/OCF Ratio | 99.53 | 26.44 | 47.45 | 16.44 | 20.11 | 184.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.80 | 3.22 | 4.75 | 3.77 | 1.93 | 2.77 |
EV/EBITDA Ratio | 22.06 | 62.54 | 56.11 | 23.86 | 18.85 | 36.58 |
EV/EBIT Ratio | 25.24 | 80.89 | 66.48 | 25.81 | 21.22 | 44.59 |
EV/FCF Ratio | 160.90 | 28.65 | 50.19 | 19.90 | 20.59 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.19 | 0.19 | 0.16 | 0.14 | 0.14 | 0.31 |
Debt / EBITDA Ratio | 2.81 | 3.95 | 2.29 | 0.85 | 1.11 | 3.11 |
Debt / FCF Ratio | 12.93 | 1.99 | 2.13 | 0.73 | 1.28 | - |
Net Debt / Equity Ratio | 0.04 | -0.06 | -0.05 | -0.11 | -0.10 | 0.12 |
Net Debt / EBITDA Ratio | 0.65 | -1.30 | -0.77 | -0.73 | -0.88 | 1.35 |
Net Debt / FCF Ratio | 2.79 | -0.60 | -0.69 | -0.61 | -0.96 | -0.44 |
Asset Turnover | 0.63 | 0.62 | 0.60 | 0.74 | 0.87 | 0.78 |
Inventory Turnover | 2.85 | 3.35 | 3.04 | 3.36 | 3.87 | 3.72 |
Quick Ratio | 1.00 | 1.45 | 1.56 | 1.88 | 1.90 | 0.95 |
Current Ratio | 1.84 | 2.17 | 2.43 | 2.85 | 2.95 | 1.62 |
Return on Equity (ROE) | 9.02% | 7.15% | 11.72% | 17.47% | 16.68% | 12.12% |
Return on Assets (ROA) | 2.52% | 1.53% | 2.67% | 6.79% | 4.95% | 3.01% |
Return on Invested Capital (ROIC) | 4.89% | 3.24% | 5.49% | 14.01% | 10.11% | 7.39% |
Return on Capital Employed (ROCE) | 4.90% | 3.00% | 5.00% | 12.50% | 8.80% | 5.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.82% | 2.62% | 3.06% | 4.43% | 6.24% | 4.03% |
FCF Yield | 0.63% | 3.45% | 1.99% | 4.91% | 4.61% | -8.78% |
Dividend Yield | 2.49% | 2.38% | 2.82% | 3.19% | 5.82% | 4.60% |
Payout Ratio | 106.54% | 137.80% | 92.63% | 65.15% | 65.55% | 118.62% |
Buyback Yield / Dilution | -0.65% | -0.45% | -0.61% | -2.85% | -7.68% | 0.14% |
Total Shareholder Return | 1.84% | 1.93% | 2.21% | 0.35% | -1.86% | 4.74% |